
Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
latest_posts
- 1
Everything to know about NASA's moon mission launching this week - 2
Kate Hudson, 46, says she doesn't need long workouts to feel good - 3
Winter storm headed for Midwest to Northeast. Here's how much snow to expect. - 4
Vote In favor of Your Favored Web-based Book Retailor - 5
Instructions to Pick the Ideal Pre-assembled Home for Your Necessities
5 Great High-Mileage Electric Vehicles Of 2024
Wolf Bites Woman in Shocking Attack at Busy Shopping Center
A definitive Manual for the Over-Ear Earphones
‘Slender Man’ attacker back in custody. What we know about Morgan Geyser's disappearance and what happens next.
Figure out How to Track the Establishment of New 5G Pinnacles
Environmental groups urge Germany to cut oil and gas dependence
Doulas play essential roles in reproductive health care – and more states are beginning to recognize it
Instructions to Keep up with Your Traded Teeth for Life span
Poll: 62% of Americans would oppose U.S. military action in Greenland













